Hydroxychloroquine (plaquenil) is an old antimalarial agent that has immunomodulatory effects widely used in SLE, in which it decreases mortality and the likelihood of developing lupus nephritis, a very common complication of SLE. It works by inhibiting the processing effects of peptide antigens and their assembly into major histocompatibility complex by antigen presenting cells.